10-Q
Quarterly Report
Actuate Therapeutics, Inc.
ACTU
NASDAQ
CIK: 1652935
File #: 001-42139
Balance Sheet
31 line items · 2 periods
XBRL
| Item | Jun 30, 2025 | Dec 31, 2024 |
|---|---|---|
ASSETS | ||
Current assets: | ||
Cash and Cash Equivalents | 6,492,656 | 8,641,622 |
Other Non-Operating Current Assets | 195,903 | 566,278 |
Total current assets | 6,688,559 | 9,207,900 |
Other Non-Operating Non-Current Assets | 280,342 | 110,548 |
Total assets | 6,968,901 | 9,318,448 |
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT) | ||
Current liabilities: | ||
Accounts Payable | 3,171,015 | 1,921,189 |
Other Non-Operating Current Liabilities | 4,570,631 | 5,921,908 |
Other Current Liabilities | 1,388,118 | 888,449 |
Other Non-Operating Current Liabilities | 70,957 | 70,957 |
UIC License Agreement | 70,957 | 70,957 |
Total current liabilities | 9,200,721 | 8,802,503 |
Long term liabilities: | ||
Accrued interest, less current portion | 16,893 | 6,768 |
UIC License Agreement | 16,893 | 6,768 |
License payable | 404,991 | 404,991 |
Total long-term liabilities | 421,884 | 411,759 |
Total liabilities | 9,622,605 | 9,214,262 |
Stockholders’ equity (deficit): | ||
Preferred Stock | 0 | 0 |
Total Stockholders' Equity | 20 | 20 |
Total Stockholders' Equity | 141,992,554 | 132,484,015 |
Total Stockholders' Equity | (144,646,278) | (132,379,849) |
Total stockholders’ equity (deficit) | (2,653,704) | 104,186 |
Common Stock | 20 | 20 |
Additional Paid-in Capital | 141,992,554 | 132,484,015 |
Retained Earnings | (144,646,278) | (132,379,849) |
Total liabilities and stockholders’ equity (deficit) | 6,968,901 | 9,318,448 |